抑癌基因PDLIM4抗体
Enigma homolog; LIM domain protein; LIM protein RIL; PDLIM 4; PDLIM4; PDZ and LIM domain 4; PDZ and LIM domain protein 4; Reversion induced LIM protein; PDLI4_HUMAN.
磷酸化P63肿瘤抑制基因抗体
p63 (phospho S455); p63 (phospho Ser455); p-p63 (Ser455); AIS; Amplified in squamous cell carcinoma; B(p51A); B(p51B); p63 Alpha; Chronic ulcerative stomatitis protein; CUSP; DN p63 alpha 1; DNp63; EE
磷酸化糖原合酶激酶3β抗体
GSK3 beta (phospho Y216); p-GSK3 beta (phospho Y216);GSK3B(Phospho-Tyr216); GSK3B(Phospho-Y216); p-GSK-3 Beta(Tyr216); p-GSK-3 beta(Y216); Glycogen synthase kinase 3 beta; GSK 3 beta; GSK 3B; GSK3B; G
Anti-lamin A + C Polyclonal Antibody
Anti-lamin A + C Polyclonal Antibody 应用 IHC 稀释比例 IHC 1:25-100. 交叉反应 Mouse
Anti-FIS1 Polyclonal Antibody
Anti-FIS1 Polyclonal Antibody 应用 WB 稀释比例 WB 1:500-2000. 交叉反应 Human Mouse Rat
Anti-ID2 Polyclonal Antibody
Anti-ID2 Polyclonal Antibody 应用 IHC 稀释比例 IHC 1:50-200. 交叉反应 Human
Anti-DDX3 单克隆抗体
Anti-DDX3 Monoclonal Antibody 应用 WB IP ICC 稀释比例 WB 1:1000. ICC 1:200.